FIG 1.
Seroprevalence, maternal infection risk, fetal transmission risk, and congenital infection risk of the following selected infections: TOXO, PB19, rubella, CMV, and ZIKV. Seroprevalence at childbearing age is shown. IR/year, maternal annual infection rate; FTR, fetal transmission rate; CIR, congenital infection rate, determined as the number of congenital infections per 1,000 live births (TOXO) or per 1,000 pregnancies (RV, CMV, PB19, and ZIKV).
